from the ClinicalTrials.gov record
This study is testing a new, less invasive way to perform breast cancer surgery using a single-port robotic system (a robot-assisted surgical tool made in China, called the Shurui SR-ENS-600). The robot works through one small hidden incision (about 3-4 cm) in the armpit or under the breast fold, instead of multiple cuts or a large open wound.
We want to find out whether this robot-assisted surgery is safe and effective for women with early-stage breast cancer who need either:
Breast-conserving surgery (lumpectomy), or
Total removal of breast tissue with immediate reconstruction using a breast implant.
You may be able to join if you:
Are a woman aged 18-70 years;
Have been diagnosed with early-stage breast cancer (by biopsy);
Are suitable for either breast-conserving surgery or mastectomy with immediate implant reconstruction;
Are in good general health (able to tolerate surgery and anesthesia);
Are willing to receive the robotic surgery and complete the follow-up visits.
If you join, you will:
Receive the robotic surgery as your main treatment;
Stay in the hospital for a short period after surgery (about 1-7 days);
Come back for follow-up visits at 1, 3, 6, 12, and 24 months after surgery;
Be asked to complete a few simple questionnaires about your recovery, satisfaction with breast appearance, and quality of life.